Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
US5760023A · kind A · utility
29Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 1997 |
| Grant date | Jun 2, 1998 |
| Priority date | — |
| Expiry date | Jul 14, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-pruritic pharmaceutical formulations containing kappa agonist compounds and methods of prevention or treatment of pruritus in a mammal with the anti-pruritic formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.